Eli Lilly & Co

FDA Regulatory Profile

Summary

Total Recalls
5 (1 Class I)
510(k) Clearances
7
Inspections
36
Compliance Actions
3

Known Names

eli lilly and, eli lilly and company

Recent Recalls

NumberClassProductDate
D-0445-2024Class IISterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human inMarch 12, 2024
D-0009-2022Class IGlucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for GlucaSeptember 24, 2021
D-0773-2021Class IITrulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company,August 19, 2021
D-0720-2021Class IIZyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: LiJune 29, 2021
D-0248-2019Class IIIERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, ManufactuNovember 8, 2018

Recent 510(k) Clearances

K-NumberDeviceDate
K212217Tempo Smart ButtonSeptember 16, 2022
K160949Go Dose SystemDecember 22, 2016
K142518HumaPen LuxuraJune 5, 2015
K100988HUMAPEN LUXURA HDAugust 17, 2010
K063151HUMAPEN LUXURA HDJanuary 9, 2007
K053563HUMAPEN MEMOIRApril 7, 2006
K982842HUMAPEN AND HUMAPEN ERGOSeptember 25, 1998